Is West Pharmaceutical Services Inc. (WST) a Buy? The Stock Rises Again

September 17, 2017 - By test

Investors sentiment decreased to 0.96 in Q4 2016. Its down 0.05, from 1.01 in 2016Q3. It dived, as 31 investors sold West Pharmaceutical Services Inc. shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported.
Kayne Anderson Rudnick Investment Limited Liability Co stated it has 26,173 shares. Credit Agricole S A accumulated 39,145 shares or 0.01% of the stock. Hutchin Hill Limited Partnership reported 5,700 shares. Pub Employees Retirement Association Of Colorado reported 209,624 shares or 0.14% of all its holdings. Parametrica Mngmt holds 6,784 shares. Blackrock Institutional Trust Na, California-based fund reported 2.19 million shares. Savings Bank holds 0.02% or 12,145 shares. Contravisory Mgmt Inc has 2,117 shares. Natixis owns 2,578 shares for 0% of their portfolio. Service Automobile Association reported 0.01% in West Pharmaceutical Services Inc. (NYSE:WST). Envestnet Asset Mgmt has 0.01% invested in West Pharmaceutical Services Inc. (NYSE:WST). Principal Grp Incorporated invested 0.03% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). Tortoise Invest Mgmt Lc holds 259 shares. Sei Invests holds 50 shares. The Illinois-based Nuveen Asset Mngmt has invested 0.01% in West Pharmaceutical Services Inc. (NYSE:WST).

Since May 2, 2017, it had 0 insider buys, and 2 selling transactions for $5.63 million activity. Malone Daniel sold $384,816 worth of West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, May 2.

The stock of West Pharmaceutical Services Inc. (NYSE:WST) is a huge mover today! The stock increased 4.59% or $4.21 on September 15, reaching $95.91. About 761,446 shares traded or 112.33% up from the average. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since September 17, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.
The move comes after 8 months positive chart setup for the $7.10B company. It was reported on Sep, 17 by Barchart.com. We have $102.62 PT which if reached, will make NYSE:WST worth $497.00M more.

Investors wait West Pharmaceutical Services Inc. (NYSE:WST) to report on October, 26. its quarterly earnings Wall Street analysts expect $0.53 earnings per share, $0.00 or 0.00 % from last year’s $0.53 same quarter earnings. This translates into $39.23 million profit for WST giving the stock a 45.24 P/E. This is assuming the current $0.53 EPS is accurate. West Pharmaceutical Services Inc.’s Wall Street analysts see 3.92 % EPS growth, taking into account the $0.51 EPS reproted in the previous quarter,

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Among 3 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 10 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, June 6 with “Hold” rating. Jefferies maintained West Pharmaceutical Services Inc. (NYSE:WST) rating on Thursday, July 27. Jefferies has “Hold” rating and $9600 target. Zacks downgraded the stock to “Hold” rating in Tuesday, August 4 report. As per Friday, September 15, the company rating was upgraded by Jefferies. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Outperform” rating given on Friday, October 28 by Wells Fargo. The rating was downgraded by Wells Fargo to “Market Perform” on Wednesday, September 21. The stock of West Pharmaceutical Services Inc. (NYSE:WST) earned “Outperform” rating by Wells Fargo on Tuesday, March 22. Janney Capital initiated the stock with “Buy” rating in Friday, January 8 report. The firm has “Hold” rating given on Monday, September 11 by Jefferies. The rating was maintained by Jefferies on Thursday, June 29 with “Hold”.

More news for West Pharmaceutical Services Inc. (NYSE:WST) were recently published by: Prnewswire.com, which released: “West Announces Fall Investor Conference Schedule” on August 25, 2017. Nasdaq.com‘s article titled: “West Pharmaceutical Services (WST) Shares Cross Above 200 DMA” and published on September 01, 2017 is yet another important article.

West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $7.10 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 40.96 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.